27 CooperA
For example, metabolomics can identify biomarkers associated with specific diseases, aiding in early diagnosis and monitoring disease progression [272, 273]
WARNING: This product is intended for research and development (R&D) purposes
Nevertheless, these findings point to complex interaction between GLP-1 and the gut, brain, immune system, and gut microbiota in control of inflammation (Figure 3 and Figure 4), offering osteoarthritis as a relevant inflammation model to explore the systemic, integrative actions of GLP-1 medicines beyond metabolic control (Figure 4)
The Gala GLP-1 Tracker brings together everything you need to manage your treatmentdosage, progress, medication management, and care supportin one seamless, beautifully designed platform